Delivery Order SPE2DB24D1021-SPE2DB24FETVE

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the supply of Acyclovir 200 mg/5 ml suspension, a pharmaceutical product used for the treatment of various viral infections. The contract has a ceiling value of $1,076.33 and a period of performance ending on May 8, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of 4,568,533,609 units of ACYCLOVIR 200 MG/5 ML SUSP 473ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order has a ceiling value of $1,938.57 and a completion date of June 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This delivery order is part of a larger $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACYCLOVIR 1,000 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $1,290.99. The contract has a firm fixed price pricing type and an ultimate completion date of May 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 mg/20 ml acyclovir vials. The contract has a firm fixed price and has a total ceiling value of $1,934.24. The contract is not set-aside and is designated as an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,037.41 delivery order is for the supply of 4,557,986,323 units of Acyclovir 1,000 mg/20 ml vials. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at seventy-five thousand nine hundred twenty dollars for the supply of five hundred capsules of the antiviral medication acyclovir. As a prime contractor supporting DLA's medical supply needs, Amerisourcebergen will deliver the pharmaceutical from its facility in Conshohocken, Pennsylvania within the one day period of performance specified between August 30th and 31st, 2023. No...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valacyclovir HCL 1 gram tablets. The contract has a firm fixed price of $2,019.74 and a period of performance through April 30, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency Troop Support Medical awarded a $128,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of 400 mg acyclovir. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility on behalf of the Defense Logistics Agency, which supports the medical readiness of the U.S. Armed Forces. No subcontractors or set aside designations were identified in the award information....
This is a $11,332.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90 units of the drug Valacyclovir 1GM. The contract has an ultimate completion date of July 10, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military...
This federal contract award is for the delivery of Valacyclovir HCL 500 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,751.45 firm fixed-price delivery order was awarded on June 26, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of June 27, 2025. The contract is not set aside and allows for the supply of both brand-name and generic medications to support military healthcare programs. Amerisourcebergen Drug Corp also...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FETVE
    Delivery Order

This is a $1,787.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565664392 - Acyclovir 200 mg/5 ml suspension in 473 ml bottles. The contract has a completion date of September 4, 2024 and was awarded on September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military healthcare. The contract has no set-aside designation.

Generated 12/3/24, 9:49 AM